DERM - CIK 0001867066
The table below shows Journey Medical Corp's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$12.44M | -$9.13M | $5.24M | -$13.53M | -$2.18M | $5.13M |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | - | -$15.00M | -$5.00M | -$20.00M | -$10.00M | -$1.20M |
| Dividends paid | - | - | - | - | - | - |
Journey Medical Corp reported operating cash flow of -$12.44M for fiscal year 2025. That is down 36.3% from -$9.13M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from $5.13M (FY 2020) to -$12.44M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $16.23M | $16.99M | -$4.80M | $16.46M | $53.02M | -$487.00K |